Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

lacidipine

Known as: diethyl 2,6-dimethyl-4-(2-((E)-2-((2-methylpropan-2-yl)oxycarbonyl)ethenyl)phenyl)-1,4-dihydropyridine-3,5-dicarboxylate, lacidipine [Chemical/Ingredient] 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Background—In high-cardiovascular-risk treated hypertensive patients, the incidence of cardiovascular events has been reported to… Expand
Is this relevant?
Highly Cited
2010
Highly Cited
2010
The aim of this study was to develop and optimize SNEDDS formulations containing surfactants reported to be bioenhancers for… Expand
Is this relevant?
Highly Cited
2010
Highly Cited
2010
The purpose of the present study was to develop and optimize the microemulsion based transdermal therapeutic system for… Expand
Is this relevant?
Review
2004
Review
2004
 
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND Most cardiovascular events associated with hypertension are complications of atherosclerosis. Some antihypertensive… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Baseline data from the European Lacidipine Study on Atherosclerosis (ELSA) have shown that carotid intima-media… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND AND OBJECTIVE The European Lacidipine Study of Atherosclerosis (ELSA) is a prospective, randomized, double-blind… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
BACKGROUND The possibility that calcium antagonists exert an anti-atherosclerotic action at least partly independently of the… Expand
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Essential hypertension is characterized by impaired endothelium-dependent vasodilation. The present study was designed to test… Expand
Is this relevant?
1992
1992
Lacidipine, a new, long-acting antihypertensive dihydropyridine calcium antagonist was tested for potential antioxidant effect in… Expand
Is this relevant?